TipRanks
Advertisement
Advertisement
IGC Pharma strengthens regulatory readiness of Phase 2 CALMA trial
PremiumThe FlyIGC Pharma strengthens regulatory readiness of Phase 2 CALMA trial
2M ago
IGC Pharma evaluates potential civil remedies following federal jury verdict
Premium
The Fly
IGC Pharma evaluates potential civil remedies following federal jury verdict
3M ago
IGC Pharma CEO, principal financial officer purchase over $1.15M of stock
Premium
The Fly
IGC Pharma CEO, principal financial officer purchase over $1.15M of stock
4M ago
IGC Pharma adds Mount Sinai clinical site as CALMA trial advances
PremiumThe FlyIGC Pharma adds Mount Sinai clinical site as CALMA trial advances
5M ago
IGC Pharma to present new Tau-PET biomarker research at Global Tau conference
Premium
The Fly
IGC Pharma to present new Tau-PET biomarker research at Global Tau conference
5M ago
Roth views partial cannabis re-scheduling order as ‘extremely favorable’
Premium
The Fly
Roth views partial cannabis re-scheduling order as ‘extremely favorable’
6M ago
IGC Pharma Secures New Promissory Note Financing Agreements
PremiumCompany AnnouncementsIGC Pharma Secures New Promissory Note Financing Agreements
6M ago
IGC Pharma secures Colombian authorization for psilocybin research
Premium
The Fly
IGC Pharma secures Colombian authorization for psilocybin research
6M ago
IGC Pharma reaches 80% enrollment in Phase 2 CALMA trial
Premium
The Fly
IGC Pharma reaches 80% enrollment in Phase 2 CALMA trial
6M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―